Down Syndrome Biomarker Initiative (DSBI)

Key facts

Sponsor

Michael Rafii

Principal Investigator

Michael S. Rafii, MD, PhD

University of California, San Diego

Enrollment

12 enrolled

Eligibility

30-60 years · All sexes

Timeline

2013 – 2017

Study locations (1)

• University of California, San Diego, La Jolla, California, United States

Collaborators

Janssen Research & Development, LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07416201
  Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
  National Institute of Allergy and Infectious Diseases (NIAID)
• RECRUITINGNANCT07484464
  Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down Syndrome
  Riphah International University
• RECRUITINGNCT07195253
  Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome
  Hospices Civils de Lyon
• RECRUITINGNANCT07296861
  HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome
  UNC Lineberger Comprehensive Cancer Center
• RECRUITINGPHASE4NCT07280468
  Endotype DIrected Treatment for OSA in Down Syndrome
  University of Arizona
• ENROLLING BY INVITATIONNCT07413224
  Qualitative Effects of AEF0217 in Down Syndrome People
  Aelis Farma
• RECRUITINGNANCT07425769
  Adapting RDAD for DS
  University of Kansas Medical Center
• RECRUITINGPHASE2NCT07242638
  Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
  Icahn School of Medicine at Mount Sinai

See all trials for Down syndrome →